Chronic Pancreatitis Does Not and Causing Pancreatitis

Total Page:16

File Type:pdf, Size:1020Kb

Chronic Pancreatitis Does Not and Causing Pancreatitis Pancreatitis National Digestive Diseases Information Clearinghouse Pancreatitis is an inflammation of the pan- creas. The pancreas is a large gland behind the stomach and close to the duodenum. The duodenum is the upper part of the National Institute of small intestine. The pancreas secretes Diabetes and digestive enzymes into the small intestine Digestive and Kidney through a tube called the pancreatic duct. Diseases These enzymes help digest fats, proteins, NATIONAL and carbohydrates in food. The pancreas INSTITUTES also releases the hormones insulin and OF HEALTH glucagon into the bloodstream. These hormones help the body use the glucose it derives from food for energy. threatening illness with many complica- Normally, digestive enzymes do not tions. About 80,000 cases occur in the become active until they reach the small United States each year; some 20 percent intestine, where they begin digesting food. of them are severe. But if these enzymes become active inside the pancreas, they start “digesting” it. Acute pancreatitis is usually caused by drinking too much alcohol or by gallstones. Acute pancreatitis occurs suddenly and A gallstone can block the pancreatic duct, lasts for a short period of time and usually trapping digestive enzymes in the pancreas resolves. Chronic pancreatitis does not and causing pancreatitis. Some prescrip- resolve itself and results in a slow destruc- tion drugs, pancreatic or intestinal abnor- tion of the pancreas. Either form can cause malities, abdominal trauma, or surgery can serious complications. In severe cases, also cause pancreatitis. In some cases, bleeding, tissue damage, and infection may recurrent pancreatitis is hereditary and occur. Cysts, which are fluid-filled sacs of caused by mutations in genes. In rare tissue, may also develop. And enzymes and cases, the disease may result from infec- toxins may enter the bloodstream, injuring tions, such as mumps, and in about 15 per- the heart, lungs, and kidneys, or other cent of the cases, the cause is unknown. organs. Symptoms Acute Pancreatitis Acute pancreatitis usually begins with pain Some people have more than one attack in the upper abdomen that may last for a and recover completely after each, but few days. The pain may be severe and may acute pancreatitis can be a severe, life- become constant—just in the abdomen—or it may reach to the back and other areas. It may be sudden and intense or begin as a Treatment mild pain that gets worse when food is Treatment depends on how bad the attack eaten. Someone with acute pancreatitis is. If no complications in the form of kid- often looks and feels very sick. Other ney failure or lung problems occur, acute symptoms may include pancreatitis usually improves on its own. • swollen and tender abdomen Treatment is designed to support vital func- tions and prevent complications. A hospi- • nausea tal stay will be necessary so that fluids can be replenished intravenously. • vomiting Acute pancreatitis can also cause breathing • fever problems. Many people develop hypoxia, • rapid pulse which means that cells and tissues are not receiving enough oxygen. Doctors treat Severe cases may cause dehydration and hypoxia by giving oxygen through a face low blood pressure. The heart, lungs, or mask. Despite treatment, some people kidneys may fail. If bleeding occurs in the still experience lung failure and require a pancreas, shock and sometimes even death ventilator. follow. If pancreatic cysts occur and are considered Diagnosis large enough to interfere with the pan- creas’s healing, your doctor may drain or Besides asking about a person’s medical surgically remove the cysts. history and doing a physical exam, a doctor will order a blood test to diagnose acute Sometimes a person cannot stop vomiting pancreatitis. During acute attacks, the and needs to have a tube placed in the blood contains at least three times more stomach to remove fluid and air. In mild amylase and lipase than usual. Amylase cases, a person may not eat for 3 or 4 days and lipase are digestive enzymes formed in and instead may receive fluids and pain the pancreas. Changes may also occur in relievers through an IV (intravenous) line. blood levels of glucose, calcium, magne- sium, sodium, potassium, and bicarbonate. Unless the pancreatic duct or bile duct is After the pancreas improves, these levels blocked by gallstones, an acute attack usu- usually return to normal. ally lasts only a few days. In severe cases, a person may be fed intravenously for 3 to A doctor may also order an abdominal 6 weeks while the pancreas slowly heals. ultrasound to look for gallstones and a This process is called total parenteral nutri- CAT (computerized axial tomography) scan tion. However, for mild cases of the dis- to look for inflammation or destruction of ease, total parenteral nutrition offers no the pancreas. CAT scans are also useful in benefit. locating pseudocysts. (See the section on chronic pancreatitis.) 2 Pancreatitis If an infection develops, the doctor may Chronic Pancreatitis prescribe antibiotics. Surgery may be needed for extensive infections. Surgery If injury to the pancreas continues, from may also be necessary to find the source of drinking alcohol, for example, chronic pan- bleeding, to rule out problems that resem- creatitis may develop. Chronic pancreatitis ble pancreatitis, or to remove severely occurs when digestive enzymes attack and damaged pancreatic tissue. destroy the pancreas and nearby tissues, causing scarring and pain. The usual cause Before leaving the hospital, a person will be of chronic pancreatitis is many years of advised not to drink alcohol and not to eat alcohol abuse, but the chronic form may large meals. After all signs of acute pancre- also be triggered by only one acute attack, atitis are gone, the doctor will try to decide especially if the pancreatic ducts are dam- what caused it in order to prevent future aged. The damaged ducts cause the pan- attacks. In some people, the cause of the creas to become inflamed, tissue to be attack is clear, but in others, more tests are destroyed, and scar tissue to develop. needed. Damage from alcohol abuse may not appear for many years, and then a person may have a sudden attack of pancreatitis. Gallstones and In 70 to 80 percent of adult patients, chron- ic pancreatitis appears to be caused by alco- Pancreatitis holism. This form is more common in men Gallstones can cause pancreatitis and than in women and often develops between they usually require surgical removal. the ages of 30 and 40. Ultrasound or a CAT scan can detect gallstones and can sometimes give an Chronic pancreatitis may also occur when idea of the severity of the pancreatitis. the pancreatic duct is blocked or narrowed When gallstone surgery can be sched- because of trauma or because pseudocysts uled depends on how severe the pan- have formed. Pseudocysts are cyst-like creatitis is. If the pancreatitis is mild, buildups of pancreatic fluid in the duct. gallstone surgery may proceed within Some drugs can cause chronic pancreatitis about a week. More severe cases may too. In many cases, however, the cause is mean gallstone surgery is delayed for unknown. People with chronic pancreatitis a month or more. may have one or even all three of the fol- After the gallstones are removed and lowing problems: pain, diabetes, or malab- inflammation goes away, the pancreas sorption of food leading to weight loss. usually returns to normal. In some cases, chronic pancreatitis is inher- ited. Hereditary pancreatitis usually begins in childhood but may not be diagnosed for several years. A person with hereditary pancreatitis usually has the typical symp- toms that come and go over time. Episodes last from 2 days to 2 weeks. 3 Pancreatitis A determining factor in the diagnosis of Using ultrasonic imaging, endoscopic retro- hereditary pancreatitis is two or more fam- grade cholangiopancreatography (ERCP), ily members with pancreatitis in more than and CAT scans, a doctor can see problems one generation. Treatment for individual indicating chronic pancreatitis. Such prob- attacks is usually the same as it is for acute lems include calcification of the pancreas, pancreatitis. Any pain or nutrition prob- in which tissue hardens from deposits of lems are treated just as they are for chronic insoluble calcium salts. In more advanced pancreatitis. Surgery can often ease pain stages of the disease, when diabetes and and help manage complications. malabsorption occur, a doctor can use a number of blood, urine, and stool tests to Symptoms help diagnose chronic pancreatitis and to Some people have no pain, but most do. monitor its progression. Pain in the back and abdomen may be constant and disabling. In certain cases, Treatment abdominal pain goes away as the condition Relieving pain is the first step in treating advances, probably because the pancreas is chronic pancreatitis. The next step is to no longer making digestive enzymes. plan a diet that is high in carbohydrates and low in fat. People with chronic disease often lose weight, even when their appetite and eating A doctor may prescribe pancreatic enzymes habits are normal. The weight loss occurs to take with meals if the pancreas does not because the body does not secrete enough secrete enough of its own. The enzymes pancreatic enzymes to break down food, so should be taken with every meal to help the nutrients are not absorbed normally. Poor body digest food and regain some weight. digestion leads to excretion of fat, protein, Sometimes insulin or other drugs are and sugar into the stool. If the insulin- needed to control blood glucose. producing cells of the pancreas (islet cells) have been damaged, diabetes may also In some cases, surgery is needed to relieve develop at this stage. pain. The surgery may involve draining an enlarged pancreatic duct or removing part Diagnosis of the pancreas.
Recommended publications
  • Hereditary Pancreatitis
    Fact Sheet - Hereditary Pancreatitis Hereditary Pancreatitis (HP) is a rare genetic condition characterized by recurrent episodes of pancreatic attacks, which can progress to chronic pancreatitis. Symptoms include abdominal pain, nausea, and vomiting. Onset of attacks typically occurs between within the first two decades of life, but can begin at any age. In the United States, it is estimated that at least 1,000 individuals are affected with hereditary pancreatitis. HP has also been linked to an increased lifetime risk of pancreatic cancer. Pancreatic cancer is the 4th leading cause of cancer deaths among Americans. Individuals with hereditary pancreatitis appear to have a 40% lifetime risk of developing pancreatic cancer. This increased risk is heavily dependent upon the duration of chronic pancreatitis and environmental exposures to alcohol and smoking. One recent study suggested that individuals with chronic pancreatitis for more than 25 years had a higher rate of pancreatic cancer when compared to individuals in the general population. This increased rate appears to be due to the prolonged chronic pancreatitis rather than having a gene mutation (all cationic trypsinogen mutations). It is important to note that these risk values may be higher than expected because these studies on pancreatic cancer use a highly selective population rather than a randomly selected population. At this time, there is no cure for HP. Treating the symptoms associated with HP is the choice method of medical management. Patients may be prescribed pancreatic enzyme supplements to treat maldigestion, insulin to treat diabetes, analgesics and narcotics to control pain, and lifestyle changes to reduce the risk of pancreatic cancer (for example, NO SMOKING!).
    [Show full text]
  • Idiopathic and Hereditary Pancreatitis Testing
    Idiopathic and Hereditary Pancreatitis Testing Pancreatitis is a relatively common disorder with multiple etiologies that causes inammation in the pancreas. Acute pancreatitis (AP) is a result of sudden inammation, and patients may present with increased pancreatic enzyme concentrations. Chronic Tests to Consider pancreatitis (CP) is a syndrome of progressive inammation that may lead to permanent damage to pancreatic structure and function. Genetic testing can be utilized to determine Pancreatitis, Panel (CFTR, CTRC, PRSS1, a genetic cause of idiopathic or hereditary AP or CP and/or to assess risk of disease in SPINK1) Sequencing (Temporary Referral as of 12/7/20) 2010876 family members. Method: Polymerase Chain Reaction/Sequencing Preferred test for individuals with history of Disease Overview idiopathic pancreatitis Pancreatitis (CTRC) Sequencing 2010703 Incidence/Prevalence Method: Polymerase Chain Reaction/Sequencing Chronic pancreatitis For adults with idiopathic pancreatitis if other components of panel (CFTR , PRSS1 , SPINK1 ) Incidence: ~4-12/100,000 per year 1 have been sequenced without providing a Prevalence: ~37-42/100,000 1 complete explanation for the pancreatitis Idiopathic chronic pancreatitis is more common than previously thought 2 Pancreatitis (PRSS1) Sequencing and Deletion/Duplication (Temporary Referral Symptoms/Presentation Etiologies as of 01/14/21) 3001768 Method: Polymerase Chain Reaction/Sequencing Acute Sudden onset of pain in Common and Multiplex Ligation Dependent Probe Amplic- pancreatitis the upper abdomen,
    [Show full text]
  • Hereditary Pancreatitis: Outcomes and Risks
    HEREDITARY PANCREATITIS: OUTCOMES AND RISKS by Celeste Alexandra Shelton BS, University of Pittsburgh, 2013 Submitted to the Graduate Faculty of the Graduate School of Public Health in partial fulfillment of the requirements for the degree of Master of Science University of Pittsburgh 2015 UNIVERSITY OF PITTSBURGH Graduate School of Public Health This thesis was presented by Celeste Alexandra Shelton It was defended on April 7, 2015 and approved by Thesis Director David C. Whitcomb, MD, PhD, Chief, Division of Gastroenterology, Hepatology and Nutrition, Giant Eagle Foundation Professor of Cancer Genetics, Professor of Medicine, Cell Biology & Physiology and Human Genetics, School of Medicine, University of Pittsburgh Committee Members Randall E. Brand, MD, Professor of Medicine, School of Medicine, University of Pittsburgh, Academic Director, GI-Division, UPMC Shadyside, Dir., GI Malignancy Early Detection, Diagnosis & Prevention Program, Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Robin E. Grubs, PhD, LCGC, Assistant Professor, Director, Genetic Counseling Program, Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh John R. Shaffer, PhD, Assistant Professor, Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh ii Copyright © by Celeste Shelton 2015 iii HEREDITARY PANCREATITIS: OUTCOMES AND RISKS Celeste A. Shelton, MS University of Pittsburgh, 2015 ABSTRACT Pancreatitis is an inflammatory disease of the pancreas that was first identified in the 1600s. Symptoms for pancreatitis include intense abdominal pain, nausea, and malnutrition. Hereditary pancreatitis (HP) is a genetic condition in which recurrent acute attacks can progress to chronic pancreatitis, typically beginning in adolescence. Mutations in the PRSS1 gene cause autosomal dominant HP.
    [Show full text]
  • Prevalence of Pancreatitis in Female and Male Pediatric Patients in Eastern Kentucky in the United States
    Central Journal of Family Medicine & Community Health Research Article *Corresponding author Karin N. Westlund, Department of Physiology, University of Kentucky, MS-508 Medical Science Building, 800 Prevalence of Pancreatitis in Rose, Lexington, KY, 40536-0298, USA, Tel: 859-323-0672 or -33668; Email: Submitted: 23 August 2016 Female and Male Pediatric Accepted: 10 November 2016 Published: 12 November 2016 Patients in Eastern Kentucky in ISSN: 2379-0547 Copyright the United States © 2016 Westlund et al. OPEN ACCESS Sabrina L. McIlwrath and Karin N. Westlund* Department of Physiology, University of Kentucky, USA Keywords • Epidemiology • Gender difference Abstract • Recurrent acute pancreatitis Background & aims: Studies in the past decade report worldwide increase of • Tobacco use pediatric pancreatitis. The present study focuses on aUnited States region where the • Obesity first genes associated with hereditary pancreatitis were identified. Aim of the study was to investigate incidences of acute pancreatitis, recurrent acute pancreatitis, and chronic pancreatitis, collecting demographics, etiologies, and comorbid conditions using charted ICD-9-CM codes. Methods: Retrospective chart review was performed on de-identified patient records of hospitalizations at University of Kentucky hospitals between 2005 and 2013. Results: Of 234 children diagnosed during the 9 year time period, 69.2% (n=162) had a single episode of acute, 27.8% (65) recurrent acute, and 16.2% (38) chronic pancreatitis. Surprisingly, the annual incidence for first time diagnosis of acute pancreatitis was significantly higher for female patients (16.1, 95% CI: 13.5- 18.7 per 100,000, P<0.005) compared to males (9.1, 95% CI: 6.8-11.4). Comorbid conditions varied widely depending on patients’ age.
    [Show full text]
  • Genetic Testing for Hereditary Pancreatitis
    Genetic Testing for Hereditary Pancreatitis Last Review Date: October 12, 2018 Number: MG.MM.LA.28C3 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth the clinical evidence that the patient meets the criteria for the treatment or surgical procedure. Without this documentation and information, EmblemHealth will not be able to properly review the request for prior authorization. The clinical review criteria expressed below reflects how EmblemHealth determines whether certain services or supplies are medically necessary. EmblemHealth established the clinical review criteria based upon a review of currently available clinical information (including clinical outcome studies in the peer-reviewed published medical literature, regulatory status of the technology, evidence-based guidelines of public health and health research agencies, evidence- based guidelines and positions of leading national health professional organizations, views of physicians practicing in relevant clinical areas, and other relevant factors). EmblemHealth expressly reserves the right to revise these conclusions as clinical information changes, and welcomes further relevant information. Each benefit program defines which services are covered. The conclusion that a particular service or supply is medically necessary does not constitute a representation or warranty that this service or supply is covered and/or paid for by EmblemHealth, as some programs exclude coverage for services or supplies that EmblemHealth considers medically necessary. If there is a discrepancy between this guideline and a member's benefits program, the benefits program will govern. In addition, coverage may be mandated by applicable legal requirements of a state, the Federal Government or the Centers for Medicare & Medicaid Services (CMS) for Medicare and Medicaid members.
    [Show full text]
  • Abdominal Pain
    10 Abdominal Pain Adrian Miranda Acute abdominal pain is usually a self-limiting, benign condition that irritation, and lateralizes to one of four quadrants. Because of the is commonly caused by gastroenteritis, constipation, or a viral illness. relative localization of the noxious stimulation to the underlying The challenge is to identify children who require immediate evaluation peritoneum and the more anatomically specific and unilateral inner- for potentially life-threatening conditions. Chronic abdominal pain is vation (peripheral-nonautonomic nerves) of the peritoneum, it is also a common complaint in pediatric practices, as it comprises 2-4% usually easier to identify the precise anatomic location that is produc- of pediatric visits. At least 20% of children seek attention for chronic ing parietal pain (Fig. 10.2). abdominal pain by the age of 15 years. Up to 28% of children complain of abdominal pain at least once per week and only 2% seek medical ACUTE ABDOMINAL PAIN attention. The primary care physician, pediatrician, emergency physi- cian, and surgeon must be able to distinguish serious and potentially The clinician evaluating the child with abdominal pain of acute onset life-threatening diseases from more benign problems (Table 10.1). must decide quickly whether the child has a “surgical abdomen” (a Abdominal pain may be a single acute event (Tables 10.2 and 10.3), a serious medical problem necessitating treatment and admission to the recurring acute problem (as in abdominal migraine), or a chronic hospital) or a process that can be managed on an outpatient basis. problem (Table 10.4). The differential diagnosis is lengthy, differs from Even though surgical diagnoses are fewer than 10% of all causes of that in adults, and varies by age group.
    [Show full text]
  • Clinical Genetic Testing in Gastroenterology
    Clinical Genetic Testing in Gastroenterology The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Goodman, Russell P., and Daniel C Chung. 2016. “Clinical Genetic Testing in Gastroenterology.” Clinical and Translational Gastroenterology 7 (4): e167. doi:10.1038/ctg.2016.23. http:// dx.doi.org/10.1038/ctg.2016.23. Published Version doi:10.1038/ctg.2016.23 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27320331 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Citation: Clinical and Translational Gastroenterology (2016) 7, e167; doi:10.1038/ctg.2016.23 & 2016 the American College of Gastroenterology All rights reserved 2155-384X/16 www.nature.com/ctg CLINICAL AND SYSTEMATIC REVIEWS Clinical Genetic Testing in Gastroenterology Russell P. Goodman, MD, DPhil1 and Daniel C. Chung, MD1 Rapid advances in genetics have led to an increased understanding of the genetic determinants of human disease, including many gastrointestinal (GI) disorders. Coupled with a proliferation of genetic testing services, this has resulted in a clinical landscape where commercially available genetic tests for GI disorders are now widely available. In this review, we discuss the current status of clinical genetic testing for GI illnesses, review the available testing options, and briefly discuss indications for and practical aspects of such testing. Our goal is to familiarize the practicing gastroenterologist with this rapidly changing and important aspect of clinical care.
    [Show full text]
  • Progress Report Genetics and Gastroenterology
    Gut: first published as 10.1136/gut.12.7.592 on 1 July 1971. Downloaded from Gut, 1971, 12, 592-598 Progress report Genetics and gastroenterology The decade since the last review of this subject in Gut has seen considerable advances in many aspects of genetics, including the influence of heredity on disease. Compared with some specialties gastroenterology has few disorders with simple Mendelian inheritance, but in most of its conditions there is some hereditary influence. Some of the best human data illustrating a quantitative type of disease liability are those on hypertrophic pyloric stenosis and Hirschsprung's disease, and the discovery of two of the genes of the genotype giving susceptibility to duodenal ulcer is still unique. There is growing realization that both heredity and environmental factors are concerned in the aetiology of most disorders. Blood Groups and Alimentary Physiology It is still not clear what part the ABO blood group genes and the genes at the secretor, H, and Lewis loci play in alimentary physiology1. It would seem likely that they are concerned via their control of the arrangement of the sugars on the molecules of the mucus of the upper part of the tract. Yet one would not expect such slight variations between the different group specific http://gut.bmj.com/ molecules to affect their physicochemical properties. Furthermore, the dis- covery of the close relationship between the serum content ofjejunal alkaline phosphatase and the ABO blood group and secretor status2,3,4 suggests that the blood group genes are pleiotropic. In addition to their well known, and possibly unimportant, effect on the serological specificity of glycoproteins, these genes may be concerned in more fundamental processes such as the on October 2, 2021 by guest.
    [Show full text]
  • A Clinical Study of Chronic Pancreatitis
    Gut: first published as 10.1136/gut.4.3.193 on 1 September 1963. Downloaded from Gut, 1963, 4, 193 A clinical study of chronic pancreatitis OLIVER FITZGERALD, PATRICK FITZGERALD, JAMES FENNELLY1, JOSEPH P. McMULLIN, AND SYLVESTER J. BOLAND From St. Vincent's Hospital and the Departments of Medicine and Therapeutics and ofSurgery, University College, Dublin EDITORIAL SYNOPSIS A series of 53 cases of chronic pancreatic disease is described and attention drawn to the frequency with which symptoms are persistent rather than intermittent. A plea is made for the use of the term 'progressive' rather than 'relapsing' in describing many of these cases. Alcohol was an unimportant factor in the aetiology. The possibility of achieving an accurate and early diagnosis using the serum secretin/pancreozymin test is emphasized. The frequent relief of symptoms and the prevention of progress of the disease by surgery, especially sphincterotomy, is recorded. While pancreatitis has been recognized for over a (Howat, 1952; Burton, Hammond, Harper, Howat, century as a cause of gastro-intestinal disturbance, Scott, and Varley, 1960). much of the literature has dealt with acute rather In this paper we propose to describe our experi- than with chronic pancreatic disease. Reports on ence with 53 cases of chronic pancreatitis, laying the latter have been published by Comfort, Gambill, particular stress on the possibility and importance and Baggenstoss (1946), by Gambill, Comfort, and of early diagnosis of the condition, that is, when Baggenstoss (1948), and by Janowitz and Dreiling minimal damage to the acinar and islet tissues has http://gut.bmj.com/ (1958) but there is still disagreement as to the usual been caused.
    [Show full text]
  • Idiopathic Acute Pancreatitis: a Review on Etiology and Diagnostic Work-Up
    Clinical Journal of Gastroenterology (2019) 12:511–524 https://doi.org/10.1007/s12328-019-00987-7 CLINICAL REVIEW Idiopathic acute pancreatitis: a review on etiology and diagnostic work‑up Giovanna Del Vecchio Blanco1 · Cristina Gesuale1 · Marzia Varanese1 · Giovanni Monteleone1 · Omero Alessandro Paoluzi1 Received: 30 January 2019 / Accepted: 19 April 2019 / Published online: 30 April 2019 © Japanese Society of Gastroenterology 2019 Abstract Acute pancreatitis (AP) is a common disease associated with a substantial medical and fnancial burden, and with an inci- dence across Europe ranging from 4.6 to 100 per 100,000 population. Although most cases of AP are caused by gallstones or alcohol abuse, several other causes may be responsible for acute infammation of the pancreatic gland. Correctly diagnosing AP etiology is a crucial step in the diagnostic and therapeutic work-up of patients to prescribe the most appropriate therapy and to prevent recurrent attacks leading to the development of chronic pancreatitis. Despite the improvement of diagnostic technologies, and the availability of endoscopic ultrasound and sophisticated radiological imaging techniques, the etiology of AP remains unclear in ~ 10–30% of patients and is defned as idiopathic AP (IAP). The present review aims to describe all the conditions underlying an initially diagnosed IAP and the investigations to consider during diagnostic work-up in patients with non-alcoholic non-biliary pancreatitis. Keywords Acute pancreatitis · Endoscopic ultrasonography · Idiopathic pancreatitis
    [Show full text]
  • Hereditary Pancreatitis
    Lab Management Guidelines v2.0.2019 Genetic Testing for Hereditary Pancreatitis MOL.TS.287.A v2.0.2019 Introduction Genetic testing for hereditary pancreatitis is addressed by this guideline. Procedures addressed The inclusion of any procedure code in this table does not imply that the code is under management or requires prior authorization. Refer to the specific Health Plan's procedure code list for management requirements. Procedures addressed by this Procedure codes guideline CASR Sequencing 81405 CFTR Deletion/Duplication Analysis 81222 CFTR Known Familial Mutation Analysis 81221 CFTR Sequencing 81223 CFTR Targeted Mutation Analysis 81479 CLDN2 Sequencing 81479 CPA1 Sequencing 81479 CTRC Known Familial Mutation Analysis 81403 CTRC Sequencing 81405 PRSS1 Deletion/Duplication Analysis 81479 PRSS1 Known Familial Mutation Analysis 81403 PRSS1 Sequencing 81404 PRSS1 Targeted Mutation Analysis 81401 SPINK1 Deletion/Duplication Analysis 81479 SPINK1 Known Familial Mutation Analysis 81403 SPINK1 Sequencing 81404 © eviCore healthcare. All Rights Reserved. 1 of 12 400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924 www.eviCore.com Lab Management Guidelines v2.0.2019 What is pancreatitis Definition Pancreatitis is inflammation of the pancreas that may be acute, acute recurrent, or chronic.1 Acute pancreatitis is defined as two of the three following findings:2 Abdominal pain Elevated serum amylase or lipase (greater than 3x the upper limit of normal) Findings consistent with pancreatic inflammation on abdominal imaging Acute recurrent pancreatitis is defined as multiple (2 or more), discrete episodes of acute pancreatitis without any evidence of chronic pancreatitis. There must be complete resolution of clinical and laboratory findings between episodes. Chronic pancreatitis is defined as an irreversible fibro-inflammatory process which leads to permanent changes in the pancreatic parenchyma and function.
    [Show full text]
  • FINAL Vop Pancreatitis Report
    The meeting was made possible by the following sponsors: The meeting & report were supported by the following partners: TITLE: Pancreatitis Externally-Led, Patient-Focused Drug Development Meeting Contributors National Pancreas Foundation Dana K. Andersen, MD, Board of Chair David Bakelman, CEO Brooke Campbell, National Programs Coordinator Jane Holt, Co-Founder Sokphal Tun, National Program Director FCS Foundation Melissa Goetz, Co-President Mission: Cure Megan Golden, Co-Director Linda Martin, Co-Director Rebecca’s Wish Christyn Taylor, President Consulting Partners Health and Medicine Counsel of Washington: Dale Dirks and Dane Christiansen Hyman, Phelps & McNamara, P.C.: James Valentine, JD, MHS and Larry Bauer, RN, MA Disclosures No company received any benefits from supporting the EL-PFDD meeting and none were involved in the planning of the meeting. The National Pancreas Foundation, FCS Foundation, Mission: Cure, and Rebecca’s Wish are non-profit patient advocacy organizations that receive funding from pharmaceutical companies in the form of unrestricted grants and sponsorship of programs and events. Dale Dirks and Dane Christiansen are employed by the Health and Medicine Counsel, a government relations firm that primarily represents non-profits patient organizations in advocacy efforts. They provided technical assistance and advice as NPF planned the meeting and reviewed the Voice of the Patient report. James Valentine and Larry Bauer are employed by Hyman, Phelps & McNamara, P.C., a law firm that represents sponsors development drugs and patient advocacy organizations. These organizations helped fund the cost of the Externally-Led PFDD meeting: Abbvie, ChiRhoClin, Inc., Digestive Care Inc., Sagent Disclosures: No company received and benefits from supporting the PFDD meeting and were not involved in the coordination of the meeting Published: October 2020.
    [Show full text]